Back to Search

FORREST BEAULIEU, MD

MD

Pediatrics Physician

NPI: 1619599321Individual

Specialties, Licenses & Credentials

Pediatrics PhysicianPrimary

Pediatrics

Code: 208000000X

MT219863(PA)

Research & Publications (14)

Automatic generation of anatomy-based MLC fields in aperture-based IMRT.
PMID 15259658·Med Phys·2004
8-other
Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients.
PMID 19135749·Radiother Oncol·2009
8-other
Clinical outcome of adjuvant treatment of endometrial cancer using aperture-based intensity-modulated radiotherapy.
PMID 18294780·Int J Radiat Oncol Biol Phys·2008
8-other
Cutaneous myiasis: diagnosis, treatment, and prevention.
PMID 18280395·J Oral Maxillofac Surg·2008
5-case
Effects of acaricides, pyrethroids and predator distributions on populations of Tetranychus urticae in apple orchards.
PMID 18008172·Exp Appl Acarol·2007
7-preclinical
Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors.
PMID 17197177·Bioorg Med Chem Lett·2007
8-other
Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors.
PMID 17540562·Bioorg Med Chem Lett·2007
7-preclinical
Postoperative irradiation of gynecologic malignancies: improving treatment delivery using aperture-based intensity-modulated radiotherapy.
PMID 17418966·Int J Radiat Oncol Biol Phys·2007
8-other
Multiobjective optimization with a modified simulated annealing algorithm for external beam radiotherapy treatment planning.
PMID 17278824·Med Phys·2006
8-other
Mesostigmatid mites (Acari: Mesostigmata) on rainforest tree trunks: arboreal specialists, but substrate generalists?
PMID 16680564·Exp Appl Acarol·2006
4-observational
Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity.
PMID 16134929·J Med Chem·2005
7-preclinical
Discovery of a fluoroindolo[2,3-a]carbazole clinical candidate with broad spectrum antitumor activity in preclinical tumor models superior to the marketed oncology drug, CPT-11.
PMID 15801816·J Med Chem·2005
4-observational
Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor model.
PMID 15027851·J Med Chem·2004
7-preclinical
Poor performance in smooth pursuit and antisaccadic eye-movement tasks in healthy siblings of patients with schizophrenia.
PMID 11311924·Psychiatry Res·2001
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3401 CIVIC CENTER BLVD
PHILADELPHIA, PA 19104

Location

Practice Location

3401 CIVIC CENTER BLVD, PHILADELPHIA, PA
(215) 590-1220

Quick Facts

NPI
1619599321
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
14

Are you this provider?

Claim Your Profile